Proteasome inhibitors restore the STAT1 pathway and enhance the expression of MHC class I on human colon cancer cells

Proteasome inhibitors restore the STAT1 pathway and enhance the expression of MHC class I on human colon cancer cells

Abstract Background A new strategy, particularly a novel combination, for immunotherapy in microsatellite stable metastatic colorectal cancer (mCRC) treatment needs to be formulated. Studies on the interferon-γ (IFN-γ)/ Janus kinase (JAK)/ signal transducer and activator of transcription (STAT)1 pat...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Yi-Hsin Liang, Kuo-Hsing Chen, Jia-Huei Tsai, Yung-Ming Cheng, Chang-Cheng Lee, Chiu-Hwa Kao, Kuang-Yu Chan, Yeh-Ting Chen, Wen-Ling Hsu, Kun-Huei Yeh
Formato: article
Lenguaje:EN
Publicado: BMC 2021
Materias:
Colorectal cancer
Major histocompatibility complex (MHC) class I
Proteasome inhibitors
STAT1
Tumor infiltrating lymphocytes (TILs)
Interferon-γ (IFN-γ)
Medicine
R
Acceso en línea:https://doaj.org/article/e4791b98016445cf8bb98b0578157f13
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

https://doaj.org/article/e4791b98016445cf8bb98b0578157f13

Ejemplares similares